Clinical Trials Logo

Cystic Fibrosis clinical trials

View clinical trials related to Cystic Fibrosis.

Filter by:

NCT ID: NCT04469439 Recruiting - Cystic Fibrosis Clinical Trials

Impact of Sinus Surgery on Individuals With Cystic Fibrosis

Start date: July 1, 2020
Phase:
Study type: Observational

This study will be a prospective, observational study of patients who undergo endoscopic sinus surgery for cystic fibrosis-related chronic rhinosinusitis (CRS). Individuals who do not undergo surgery but are treated medically for CRS will also be enrolled to serve as a control group. Outcomes analyzed will include pulmonary, quality of life, and others.

NCT ID: NCT04468100 Completed - Cystic Fibrosis Clinical Trials

Efficacy and Safety of Tigerase® vs. Pulmozyme® in Patients With Cystic Fibrosis

Start date: August 30, 2017
Phase: Phase 3
Study type: Interventional

It is a multicenter, open-label, randomized, parallel-group study of the efficacy and safety of Tigerase® compared Pulmozyme® in patients with Cystic Fibrosis

NCT ID: NCT04467957 Active, not recruiting - Cystic Fibrosis Clinical Trials

Non-contrast Lung Perfusion Mapping Applied for New Insights in Cystic Fibrosis

Start date: November 15, 2020
Phase: Phase 4
Study type: Interventional

Cystic fibrosis (CF) results in the thickening of mucus in the lungs and other organs due to dysfunction of a transmembrane conductance protein. This allows buildup of bacteria that results in inflammation, leading to tissue breakdown and loss of function. In the lungs, this process causes loss of air exchange structures progressing to diminished lung function. The exchange of oxygen in the lungs depends on both the integrity of air conduits and vasculature. Most clinical assessments, however, focus on ventilatory function, with the assumption that any vascular compromise is secondary. Nevertheless, there is evidence, some from the investigator's lab, to suggest that perfusion anomalies in the lung occur before signs of ventilatory dysfunction. Thus, the inflammatory processes of CF may impact pulmonary microvasculature specifically and concurrently or prior to damage to ventilatory structures. This study aims to apply a new MRI method to serially measure regional lung perfusion, without the use of contrast agent, in children with CF and to associate it with regional assessments of ventilation and to serum cytokines or proteomic markers of angiogenesis and inflammatory processes. The investigator's lab has recently developed a noninvasive, non-contrast, method of labeling blood flowing into the lungs and generating a map of perfusion. The investigator aims to couple this technique to existing methods using hyperpolarized Xenon to map ventilation. The investigator will apply these methods over time in CF patients, monitoring the relationship between regional perfusion and ventilation defects. This pilot work will provide the foundation for larger studies to establish the essential etiological role of perfusion deficits in CF.

NCT ID: NCT04463628 Completed - Cystic Fibrosis Clinical Trials

Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic

MUCONFIN
Start date: May 15, 2020
Phase:
Study type: Observational

Impacts of the Covid-19 epidemic and associated lockdown measures on the management, health and behaviors of cystic fibrosis patients during the 2020 epidemic

NCT ID: NCT04461561 Recruiting - Cancer Clinical Trials

Using NPT to Evaluate Providing PPC as ELNEC-PPC WBT for Nurses

ELNEC-PPC
Start date: July 1, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to explain the provision of palliative care at the end of life by the implementation of the ELNEC course, as WBT Program using the Normalization Process Theory, that focus attention on how complex interventions become routinely embedded in practice. In addition to, identify the changes implemented by the participant nurses (intervention group) in their clinical practice, after participating in WBT Program to provide Palliative Care alongside with usual care versus usual care only (control group) for children with life-limiting conditions or in the case of accidents/sudden death, at the end of life. And finally, provide findings that will assist in the interpretation of the trial results.

NCT ID: NCT04460586 Completed - Cystic Fibrosis Clinical Trials

Pharmacokinetics of Omadacycline in Cystic Fibrosis

Start date: July 1, 2021
Phase: Phase 4
Study type: Interventional

The purpose of this study is to characterize the pharmacokinetics of intravenous and oral omadacycline in patients with cystic fibrosis.

NCT ID: NCT04458129 Not yet recruiting - Cystic Fibrosis Clinical Trials

Polyethylene Glycol and Intestinal Inflammation in Cystic Fibrosis

MUCOLAX
Start date: July 8, 2020
Phase: Phase 2
Study type: Interventional

The main objective of the study is to evaluate the effectiveness of polyethylene glycol treatment on intestinal inflammation in children with cystic fibrosis. In this test, a method adapted from the Fleming one-step scheme will be used. The success rate is measured by the proportion of patients with fecal calprotectin levels < 250 µg/g at 3 months after treatment initiation.

NCT ID: NCT04453358 Not yet recruiting - Cystic Fibrosis Clinical Trials

Cystic Fibrosis Remote Monitoring System

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

The objective of this study is to determine if interactive technology (i.e. virtual coaching) that facilitates vest therapy goal setting and provides positive reinforcement will increase adherence to vest therapy for airway clearance in individuals with CF.

NCT ID: NCT04451213 Completed - Cystic Fibrosis Clinical Trials

Magnetic Resonance Imaging and Neuro-Psychological Testing In Cystic Fibrosis

Start date: August 23, 2021
Phase: N/A
Study type: Interventional

CF is a complex, inherited illness that can affect many organs of the body. The investigators have found that some patients with CF have reported more problems with memory than would be expected at their age and that patients appear to be using memory strategies to overcome memory loss. The investigators intend to objectively test memory and examine MRI images of the brain of patients with CF.

NCT ID: NCT04415268 Withdrawn - Clinical trials for Cystic Fibrosis in Children

Combined Effect of CFTR Protein Modulator Drugs and Exercise in Cystic Fibrosis

Start date: June 9, 2020
Phase: N/A
Study type: Interventional

This study aims to assess the effects of programmed exercise combined with CFTR protein modulator drugs in the cardiorespiratory fitness, strength, functional capacity and agility in a group of young patients with Cystic Fibrosis.